Phase 4 Renal Transplantation Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Disorder Related to Renal Transplantation
University of Sao Paulo General Hospital80 enrolled1 locationNCT06584773
Recruiting
Phase 4
Cytomegalovirus-specific immune monitoring to guide pre-emptive therapy surveillance protocol for prevention of cytomegalovirus infection after renal transplantation.
Cytomegalovirus infection after renal transplantation
associate Prof. Tomas Reischig, M.D., Ph.D.150 enrolled1 locationACTRN12618000913279
Active
Phase 4
OVERT Study: Optimizing Valganciclovir Efficacy in Renal Transplantation
Cytomegalovirus infection after renal transplantation
ass. Prof. Tomas Reischig, M.D., Ph.D.92 enrolled1 locationACTRN12613000554763
Active
Phase 4
Ciclosporine Azathioprine versus Tacrolimus mycophenolate mofetil in renal transplantation
Immunosuppressive treatment in renal transplantationAcute rejection and transplant survival in renal transplantation
Assistance publique des Hopitaux de Marseille300 enrolled1 locationACTRN12610000697088
Completed
Phase 4
The 2VAL Study: A trial comparing the effect of valacyclovir and valganciclovir prophylaxis against cytomegalovirus (CMV) infection after renal transplantation
Cytomegalovirus infection after renal transplantation
Tomas Reischig, M.D., Ph.D.114 enrolled1 locationACTRN12610000016033